In the first issue of each month The Pharmaceutical Journal updates the guidance
on the legal status of medicines published in the 24th edition of ‘Medicines,
ethics and practice: A guide for pharmacists’, which was published in July.
The amendments are given in bold type on the first occasion they are printed
in the list; thereafter they are repeated each month in light type. The legal
status of a product can be obtained by consulting first the latest list of amendments
and then the guide. The abbreviations used in the list are those used in the
guide and explained in the key to annotations in the body of the guide (pp21
and 61).
Human medicines
Actidose-Aqua Advance suspension P
Actos tablets POM
Adgyn Combi tablets POM
Adgyn Estro tablets POM
Adgyn Medro tablets POM
Avandia tablets POM
Carbagen CR tablets POM
Clivarine injection POM
Dermalo bath emollient GSL
Econac suppositories POM
Embrel injection POM
Ferriprox tablets POM
Herceptin infusion POM
Ibugel Forte POM
Kogenate Bayer injection POM
Lemsip Children’s Six+ Cold and ’Flu sachets GSL
Lescol XL tablets POM
Moraxen suppositories POM
Nexium tablets POM
Niquitin CQ Clear patches P
Nocutil nasal spray POM
Oilatum shampoo GSL
Oilatum Junior cream GSL
Onkotrone injection POM
Regurin tablets POM
Reminyl tablets POM
Seretide Evohaler POM
Sudafed Dual Relief capsules pack size 16 GSL, pack size 32 P
Supradyn Recharge GSL
Supralip tablets POM
Tractocile preparations POM
Ultramol soluble tablets CD Inv P
Viraferonpeg injection POM
Videx EC capsule POM
Visudyne infusion POM
Vitravene injection POM
Xenazine 25 tablets POM
Zimbacol XL tablets POM
Zyban tablets POM